Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Brimapitide Reduced Neuronal Stress Markers and Cognitive Deficits in 5XFAD Transgenic Mice.

Journal of Alzheimer's disease : JAD | 2018

Alzheimer's disease (AD) is characterized by accumulations of amyloid-β (Aβ42) and hyperphosphorylated tau proteins, associated with neuroinflammation, synaptic loss, and neuronal death. Several studies indicate that c-Jun N-terminal kinase (JNK) is implicated in the pathological features of AD. We have investigated in 5XFAD mice, the therapeutic effects of Brimapitide, a JNK-specific inhibitory peptide previously tested with higher concentrations in another AD model (TgCRND8). Three-month-old 5XFAD and wild-type littermate mice were treated by intravenous injections of low doses (10 mg/kg) of Brimapitide every 3 weeks, for 3 or 6 months (n = 6-9 per group). Cognitive deficits and brain lesions were assessed using Y-maze, fear-conditioning test, and histological and biochemical methods. Chronic treatment of Brimapitide for 3 months resulted in a reduction of Aβ plaque burden in the cortex of 5XFAD treated mice. After 6 months of treatment, cognitive deficits were reduced but also a significant reduction of cell death markers and the pro-inflammatory IL-1β cytokine in treated mice were detected. The Aβ plaque burden was not anymore modified by the 6 months of treatment. In addition to modulating cognition and amyloid plaque accumulation, depending on the treatment duration, Brimapitide seems experimentally to reduce neuronal stress in 5XFAD mice.

Pubmed ID: 29660941 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Phospho-c-Jun (Ser63) II Antibody (antibody)

RRID:AB_2130162

This unknown targets c-Jun, phospho (Ser63) II

View all literature mentions

Cleaved Caspase-3 (Asp175) Antibody (antibody)

RRID:AB_2341188

This polyclonal targets Cleaved Caspase-3 (Asp175)

View all literature mentions

JUN-human (antibody)

RRID:AB_631263

This polyclonal targets JUN

View all literature mentions

APP Antibody (antibody)

RRID:AB_10694227

This unknown targets APP

View all literature mentions

Anti Iba1, Rabbit antibody (antibody)

RRID:AB_839504

This polyclonal targets Iba1

View all literature mentions

JNK (D-2) (antibody)

RRID:AB_675864

This monoclonal targets MAPK9

View all literature mentions

Anti-phospho-JNK (Thr183/Tyr185, Thr221/Tyr223) Antibody (antibody)

RRID:AB_310412

This polyclonal targets NK (Thr183/Tyr185, Thr221/Tyr223)

View all literature mentions

Anti-ADAM 10, C-terminus (antibody)

RRID:AB_11215461

This polyclonal targets ADAM 10 C-terminus

View all literature mentions

Phospho-APP (Thr668) (D90B8) Rabbit mAb (antibody)

RRID:AB_10831197

This monoclonal targets Phospho-APP (Thr668) (D90B8) Rabbit mAb

View all literature mentions

ANOVA (software resource)

RRID:SCR_002427

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 12,2023. Matlab code for two-factor (location and year) analysis-of-variance model for the calculation of climate anomalies, in which the reference interval is specified as the full length of the dataset. This scheme avoids the affects of shorter (e.g. 1961-1990) reference intervals on the temporal evolution of the spatial standard deviation of climate anomalies. Data files provided.

View all literature mentions

GraphPad Prism (software resource)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions

Phospho-c-Jun (Ser63) II Antibody (antibody)

RRID:AB_2130162

This unknown targets c-Jun, phospho (Ser63) II

View all literature mentions